|
BPF Virtual Symposium: Targeting GPCRs with Peptide Therapeutics
May 4th, 2022 3:00 pm - 4:30 pm EDT
Join us for our second virtual event of 2022. Don't miss Sally Wang Liang, from PepLib, and Peter McNamara, from Tectonic Therapeutics, present on how they are using peptides to target G protein-coupled receptors (GPCRs).
Register for free now at https://www.boulderpeptide.org/virtual-bps/. *Please note you must be logged in to access this event. Login or create a New Profile to get started.*
This educational e-seminar is provided free of charge by the Boulder Peptide Foundation. If your company is interested in supporting this or other educational initiatives, please email sponsorship@boulderpeptide.org. |
| |
|
Interested in watching past virtual events?
Visit the VBPS page to view the March VBPS on Advancements in Oral Delivery and other past events. |
| |
November 7-10, 2022
St. Julien Hotel & Spa
Boulder, Colorado
|
| |
|
REGISTER WITH CONFIDENCE: Registrations cancelled before September 1st will be fully refunded except for a $25 processing fee. Refunds processed after September 1st will be refunded 50%. Substitutions can be made at any time by contacting us. |
| |
|
Scottish scientists say venom from sea snails could hold key to future painkillers |
|
The cone snail’s venom contains chemicals called conotoxins, which the creature uses to paralyse its... |
|
|
| |
|
Mytide Therapeutics Raises $7 Million Series A Round to Transform Peptide Manufacturing with Machine Learning |
|
BOSTON--(BUSINESS WIRE)--Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has... |
|
|
| |
|
Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies |
|
Oxford, United Kingdom, 07 March, 2022: Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased... |
|
|
| |
|
FogPharma Announces Selection of Clinical Development Candidate Directly Targeting β-Catenin |
|
CAMBRIDGE, Mass.--(BUSINESS WIRE)--FogPharma, a biopharmaceutical company pioneering a new class of precision medicines that could... |
|
|
| |
|
9 Meters Biopharma Provides Clinical Update on Two Late-Stage Pipeline Products for Short Bowel Syndrome and for Celiac Disease |
|
RALEIGH, NC / ACCESSWIRE / February 28, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage... |
|
|
| |
|
Review: Cyclic peptide drugs approved in the last two decades (2001–2021) |
|
In contrast to the major families of small molecules and antibodies, cyclic peptides, as a... |
|
|
| |
Boulder Peptide Foundation
300 Center St, Superior, CO 80027
www.boulderpeptide.org
| |
|
